A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

Elena Campaner, Alessandra Rustighi, Alessandro Zannini, +21

Nature Communications

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells

Kamil Lisek, Elena Campaner, Yari Ciani, +2

Oncotarget

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

Valeria Capaci, Lorenzo Bascetta, Marco Fantuz, +21

Nature Communications

Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

Elena Campaner, Alessandro Zannini, Mariangela Santorsola, +8

Cancers

The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress

Francesco Napoletano, Gloria Ferrari Bravo, Ilaria Anna Pia Voto, +26

Cell Reports